Keyphrases
Adjuvant Antibiotics
10%
Aminoglycosides
10%
Antibiotic Activity
10%
Antibiotic Delivery
20%
Antibiotic Development
5%
Antibiotic Discovery
10%
Antibiotic Hybrids
10%
Antibiotics
50%
Antitubercular Agents
10%
Asymmetric Bilayer
10%
ATP Synthase
10%
ATP Synthase Inhibition
10%
Bedaquiline
20%
Binding Site
5%
Bisamidine
30%
Cellular Targets
5%
Cellular Uptake
5%
Cleavable
20%
Cleavable Linker
10%
Drug Delivery System
10%
Efflux Pump
5%
Essential Proteins
10%
FDA-approved Drugs
5%
Gram-negative Bacteria
5%
Gram-negative Pathogens
10%
Hybrid Strategy
5%
If Current
10%
Linker
5%
Linker Systems
10%
Lipopolysaccharide
5%
Mechanism of Action
5%
Multidrug-resistant Infection
5%
Multidrug-resistant Pseudomonas Aeruginosa (MDRPA)
100%
Mycobacterium Tuberculosis (M. tb)
5%
Nosocomial Infection
10%
Novel Antibiotics
5%
Outer Membrane
25%
Outer Membrane Penetration
10%
Penetration Problems
10%
Periplasm
10%
Polycationic
10%
Porin Channel
10%
Pseudomonas Aeruginosa (P. aeruginosa)
15%
Pseudomonas Aeruginosa Infection
100%
Resistant Bacteria
10%
Selective Delivery
100%
Self-promotion
10%
Small Molecules
50%
Substrate Channeling
10%
Targeted Development
100%
Treatment Options
5%
Pharmacology, Toxicology and Pharmaceutical Science
Adenosine Triphosphate
16%
Adjuvant
5%
Aminoglycoside
11%
Amoxicillin
11%
Antibiotic Agent
50%
Antibiotics
44%
Bacterial Infection
5%
Bedaquiline
22%
Binding Site
5%
Drug Delivery System
5%
Drug Discovery
5%
Effusion
5%
Gram Negative Bacterium
11%
Hospital Infection
11%
Infection
16%
Infectious Agent
5%
Lipopolysaccharide
5%
Mycobacterium Tuberculosis
11%
Porin
11%
Pseudomonas aeruginosa
22%
Pseudomonas Infection
100%
Synthetase
16%